Millie
your market intelligence analyst
Search Results
81 results
Your search is now limited to «Takeda» expert search.
Pharmafile 09/20/2019 04:32
Takeda and Lundbeck have announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has chosen to authorise their drug Trintellix (vortioxetine) for the treatment of major depressive disorder, described in the companies’ press release as “depression and depressed state ...
More from Pharmafile:
Takeda Pharmaceutical 09/20/2019 03:00
Takeda and Lundbeck announce Ministry of Health, Labour and Welfare (MHLW) approval of Trintellix® in Japan.
More from Takeda Pharmaceutical:
Korean Biomedical Review 09/19/2019 01:14
Kim went on to say, “When we inform the head of the labor union in Japan of Takeda Korea’s unfair treatment for Takeda employees and the rumor about the sale of the division, the head will meet with Takeda CEO to discuss it.
More from Korean Biomedical Review:
Business Wire 09/19/2019 01:00
Takeda achieved more than double the average pharmaceutical industry sustainability score.
More from Business Wire:
Takeda Issues US Recall of NATPARA® (parathyroid hormone) for Injection Due to the Potential for Rubber Particulate.
More from Middle East North Africa Financial Network (MENAFN):
FiercePharmaManufacturing 09/12/2019 10:46
European regulators decided the risk from the particles is small enough that they haven’t asked Takeda to recall the drug there, he pointed out.
More from FiercePharmaManufacturing:
GlobeNewswire 09/03/2019 07:00
Based on the extended agreement, Kamada projects that total revenues from sales of GLASSIA to Takeda during the years 2019-2021 will be in the range of $155 million to $180 million.
More from GlobeNewswire:
ENDPOINTS 08/05/2019 09:59
Takeda is joining the growing group of big-league players enlisting the GPCR experts at Sosei Heptares for drug design work.
More from ENDPOINTS:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications